(LEN-B) Lennar - Ratings and Ratios
Homes, Land, Mortgages, Title, Multifamily
LEN-B EPS (Earnings per Share)
LEN-B Revenue
Description: LEN-B Lennar
Lennar Corporation (NYSE: LEN-B) is a U.S.-based homebuilder that operates under several geographic segments-East, Central, Texas, and West-plus Financial Services, Multifamily, and a miscellaneous “Other” segment. Its core activities include constructing and selling single-family attached and detached homes, acquiring and developing residential land, and building and managing multifamily rental properties.
Beyond construction, Lennar provides end-to-end residential financing solutions, offering mortgage origination, title, insurance, and closing services, and it also originates and securitizes commercial mortgage loans. The company’s customer base spans first-time buyers, move-up purchasers, active-adult households, and the luxury market.
Key recent metrics (as of FY 2023) show a 12% increase in home deliveries to 21,200 units, an average selling price (ASP) of roughly $400 k-up 8% year-over-year-and a net income of $1.5 bn, reflecting strong pricing power amid a tight housing inventory. However, Lennar’s exposure to interest-rate fluctuations remains a material risk; the Federal Reserve’s policy stance has been a primary driver of mortgage demand and buyer affordability in the homebuilding sector.
Sector-wide, the U.S. homebuilding industry is sensitive to the housing starts index and the existing-home sales rate, both of which have been volatile due to labor shortages and material cost inflation. Lennar’s diversified geographic footprint and its integrated financial-services platform provide a buffer against regional downturns, but the company must monitor credit-availability trends and consumer sentiment closely.
For a deeper quantitative view of LEN-B’s valuation metrics, you may find ValueRay’s analyst dashboard useful.
LEN-B Stock Overview
| Market Cap in USD | 30,996m |
| Sub-Industry | Homebuilding |
| IPO / Inception | 2003-04-23 |
LEN-B Stock Ratings
| Growth Rating | 32.8% |
| Fundamental | 46.0% |
| Dividend Rating | 69.6% |
| Return 12m vs S&P 500 | -35.7% |
| Analyst Rating | - |
LEN-B Dividends
| Dividend Yield 12m | 1.70% |
| Yield on Cost 5y | 3.67% |
| Annual Growth 5y | 33.75% |
| Payout Consistency | 92.1% |
| Payout Ratio | 20.1% |
LEN-B Growth Ratios
| Growth Correlation 3m | 13.2% |
| Growth Correlation 12m | -42.3% |
| Growth Correlation 5y | 80.8% |
| CAGR 5y | 29.77% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.72 |
| CAGR/Mean DD 3y (Pain Ratio) | 2.39 |
| Sharpe Ratio 12m | -0.58 |
| Alpha | -49.48 |
| Beta | 1.391 |
| Volatility | 35.34% |
| Current Volume | 27.6k |
| Average Volume 20d | 53.9k |
| Stop Loss | 114.1 (-3%) |
| Signal | 0.04 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.68b TTM) > 0 and > 6% of Revenue (6% = 2.09b TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA -11.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 40.96% (prev 73.27%; Δ -32.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -507.8m <= Net Income 2.68b (YES >=105%, WARN >=100%) |
| Net Debt (2.09b) to EBITDA (4.13b) ratio: 0.51 <= 3.0 (WARN <= 3.5) |
| Current Ratio 10.36 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (255.6m) change vs 12m ago -5.39% (target <= -2.0% for YES) |
| Gross Margin 14.99% (prev 40.81%; Δ -25.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 93.18% (prev 91.75%; Δ 1.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 12.55 (EBITDA TTM 4.13b / Interest Expense TTM 162.1m) >= 6 (WARN >= 3) |
Altman Z'' 7.03
| (A) 0.41 = (Total Current Assets 15.76b - Total Current Liabilities 1.52b) / Total Assets 34.88b |
| (B) 0.63 = Retained Earnings (Balance) 22.11b / Total Assets 34.88b |
| (C) 0.05 = EBIT TTM 2.03b / Avg Total Assets 37.31b |
| (D) 1.83 = Book Value of Equity 22.14b / Total Liabilities 12.13b |
| Total Rating: 7.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.03
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield -1.97% = -0.99 |
| 3. FCF Margin -1.88% = -0.70 |
| 4. Debt/Equity 0.16 = 2.49 |
| 5. Debt/Ebitda 0.51 = 2.31 |
| 6. ROIC - WACC (= -4.68)% = -5.84 |
| 7. RoE 11.21% = 0.93 |
| 8. Rev. Trend 6.11% = 0.46 |
| 9. EPS Trend -42.37% = -2.12 |
What is the price of LEN-B shares?
Over the past week, the price has changed by +5.96%, over one month by +2.45%, over three months by +13.77% and over the past year by -25.13%.
Is Lennar a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LEN-B is around 124.08 USD . This means that LEN-B is currently overvalued and has a potential downside of 5.47%.
Is LEN-B a buy, sell or hold?
What are the forecasts/targets for the LEN-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 140.3 | 19.3% |
Last update: 2025-10-17 02:29
LEN-B Fundamental Data Overview
P/E Trailing = 11.3858
P/E Forward = 13.3333
P/S = 0.8916
P/B = 1.4098
P/EG = 2.2608
Beta = 1.391
Revenue TTM = 34.77b USD
EBIT TTM = 2.03b USD
EBITDA TTM = 4.13b USD
Long Term Debt = 4.19b USD (from longTermDebt, last fiscal year)
Short Term Debt = 532.1m USD (from shortTermDebt, last fiscal year)
Debt = 3.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.09b USD (from netDebt column, last quarter)
Enterprise Value = 33.08b USD (31.00b + Debt 3.52b - CCE 1.44b)
Interest Coverage Ratio = 12.55 (Ebit TTM 2.03b / Interest Expense TTM 162.1m)
FCF Yield = -1.97% (FCF TTM -652.6m / Enterprise Value 33.08b)
FCF Margin = -1.88% (FCF TTM -652.6m / Revenue TTM 34.77b)
Net Margin = 7.72% (Net Income TTM 2.68b / Revenue TTM 34.77b)
Gross Margin = 14.99% ((Revenue TTM 34.77b - Cost of Revenue TTM 29.55b) / Revenue TTM)
Gross Margin QoQ = 22.58% (prev 9.60%)
Tobins Q-Ratio = 0.95 (Enterprise Value 33.08b / Total Assets 34.88b)
Interest Expense / Debt = 1.40% (Interest Expense 49.3m / Debt 3.52b)
Taxrate = 24.14% (190.9m / 790.7m)
NOPAT = 1.54b (EBIT 2.03b * (1 - 24.14%))
Current Ratio = 10.36 (Total Current Assets 15.76b / Total Current Liabilities 1.52b)
Debt / Equity = 0.16 (Debt 3.52b / totalStockholderEquity, last quarter 22.57b)
Debt / EBITDA = 0.51 (Net Debt 2.09b / EBITDA 4.13b)
Debt / FCF = -3.20 (negative FCF - burning cash) (Net Debt 2.09b / FCF TTM -652.6m)
Total Stockholder Equity = 23.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.70% (Net Income 2.68b / Total Assets 34.88b)
RoE = 11.21% (Net Income TTM 2.68b / Total Stockholder Equity 23.94b)
RoCE = 7.23% (EBIT 2.03b / Capital Employed (Equity 23.94b + L.T.Debt 4.19b))
RoIC = 5.44% (NOPAT 1.54b / Invested Capital 28.39b)
WACC = 10.11% (E(31.00b)/V(34.52b) * Re(11.14%) + D(3.52b)/V(34.52b) * Rd(1.40%) * (1-Tc(0.24)))
Discount Rate = 11.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.36%
Fair Price DCF = unknown (Cash Flow -652.6m)
EPS Correlation: -42.37 | EPS CAGR: -22.09% | SUE: 0.44 | # QB: 0
Revenue Correlation: 6.11 | Revenue CAGR: -5.10% | SUE: -0.66 | # QB: 0
Additional Sources for LEN-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle